Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Opening Session Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Advertisement

Advertisement




Jan
10
Today In Oncology
Flipped Nivolumab/Ipilimumab Dosing Improves Outcomes in Advanced Melanoma
In Head-to-Head Comparison, Fixed-Duration Treatment Noninferior to Continuous for Previously Untreated CLL
Researchers Create Immune Cell Atlas of Bone Marrow in Patients With Multiple Myeloma
Small Study Examines Potential of Artificial Saliva in Patients With Head and Neck Cancer
Are Food Preservatives Linked to Increased Cancer Risk
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo